Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

Christopher L D McMillan; Stacey T M Cheung; Naphak Modhiran; James Barnes; Alberto A Amarilla; Helle Bielefeldt-Ohmann; Leo Yi Yang Lee; Kate Guilfoyle; Geert van Amerongen; Koert Stittelaar; Virginie Jakob; Celia Lebas; Patrick Reading; Kirsty R Short; Paul R Young; Daniel Watterson; Keith J Chappell

doi:10.1038/s41541-021-00428-y

Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

NPJ Vaccines. 2022 Jan 5;7(1):3. doi: 10.1038/s41541-021-00428-y.

Authors

Christopher L D McMillan¹, Stacey T M Cheung², Naphak Modhiran², James Barnes³, Alberto A Amarilla², Helle Bielefeldt-Ohmann^{2

4

5}, Leo Yi Yang Lee³, Kate Guilfoyle⁶, Geert van Amerongen⁶, Koert Stittelaar⁶, Virginie Jakob⁷, Celia Lebas⁷, Patrick Reading^{3

8}, Kirsty R Short^{2

4}, Paul R Young^{9

10

11}, Daniel Watterson^{12

13

14}, Keith J Chappell^{15

16

17}

Affiliations

¹ School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. c.mcmillan1@uq.edu.au.
² School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
³ WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.
⁴ Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia.
⁵ School of Veterinary Science, The University of Queensland Gatton Campus, Gatton, QLD, 4343, Australia.
⁶ Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands.
⁷ Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland.
⁸ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3000, Australia.
⁹ School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. p.young@uq.edu.au.
¹⁰ Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia. p.young@uq.edu.au.
¹¹ The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia. p.young@uq.edu.au.
¹² School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. d.watterson@uq.edu.au.
¹³ Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia. d.watterson@uq.edu.au.
¹⁴ The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia. d.watterson@uq.edu.au.
¹⁵ School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. k.chappell@uq.edu.au.
¹⁶ Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia. k.chappell@uq.edu.au.
¹⁷ The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia. k.chappell@uq.edu.au.

No abstract available

Publication types

Published Erratum